作者: Khaled Ali , Montserrat Camps , Wayne P. Pearce , Hong Ji , Thomas Rückle
DOI: 10.4049/JIMMUNOL.180.4.2538
关键词: In vivo 、 Immunoglobulin E 、 P110δ 、 Cell Degranulation 、 Degranulation 、 Cell biology 、 Mast cell 、 Biology 、 Proto-Oncogene Proteins c-akt 、 Gene isoform
摘要: The leukocyte-enriched p110γ and p110δ isoforms of PI3K have been shown to control in vitro degranulation mast cells induced by cross-linking the high affinity receptor IgE (FceRI). However, relative contribution these IgE-dependent allergic responses vivo is controversial. A side-by-side comparative analysis role cell function, using genetic approaches newly developed isoform-selective pharmacologic inhibitors, confirms that both play an important FceRI-activated vitro. In vivo, however, only was found be required for optimal IgE/Ag-dependent hypersensitivity mice. These observations identify as a key therapeutic target among allergy- cell-related diseases.